$Novo-Nordisk A/S(NVO)$ Its un

Its undervalued right now

Healthcare Recovery: Can Hims Earnings Keep Pace With LLY and NVO?

Hims & Hers is set to report Q1 earnings, with focus on GLP-1 compounded semaglutide's quarterly revenue contribution and user growth, alongside the latest FDA regulatory developments on compounded drugs. Analyst sentiment is sharply divided — bulls argue HIMS has hedged GLP-1 compliance risk through product line diversification, while bears warn an outright FDA ban on compounded versions could trigger a steep revenue cliff. LLY delivered a strong earnings beat this season, surging 10% on the day. Can HIMS follow?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":563364612584240,"tweetId":"563364612584240","gmtCreate":1778569975345,"gmtModify":1778569978843,"author":{"id":3584090913879250,"idStr":"3584090913879250","authorId":3584090913879250,"authorIdStr":"3584090913879250","name":"Todkie","avatar":"https://static.tigerbbs.com/68110d1283e1fd53c9c0fe6ec6bccb7e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"hat":"https://static.tigerbbs.com/50a4c8d97279fa9f8f1fa9749a6bdff4","crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.03","exceedPercentage":"93.52%","individualDisplayEnabled":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"972123088c9646f7b6091ae0662215be-3","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":49,"starInvestorFlag":false},"themes":[{"themeId":"ab38a1599f2b4becb1fee7b45df87b9b","categoryId":"7a15628ce2174325bddc6229505e0d70","name":"Healthcare Recovery: Can Hims Earnings Keep Pace With LLY and NVO?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":ab38a1599f2b4becb1fee7b45df87b9b}&rnconfig={\"headerBarHidden\": true}","description":"Hims & Hers is set to report Q1 earnings, with focus on GLP-1 compounded semaglutide's quarterly revenue contribution and user growth, alongside the latest FDA regulatory developments on compounded drugs. Analyst sentiment is sharply divided — bulls argue HIMS has hedged GLP-1 compliance risk through product line diversification, while bears warn an outright FDA ban on compounded versions could trigger a steep revenue cliff. LLY delivered a strong earnings beat this season, surging 10% on the day. Can HIMS follow?","image":"https://community-static.tradeup.com/news/fd159dbf87cadcf6c3f1da47474df2e9"}],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\n<p>Its undervalued right now</p></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/NVO\">$Novo-Nordisk A/S(NVO)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\n<p>Its undervalued right now</p></body></html>","text":"$Novo-Nordisk A/S(NVO)$ Its undervalued right now","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/563364612584240","repostId":0,"isVote":1,"tweetType":1,"viewCount":209,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NVO"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":44,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/563364612584240"}